Evidence map›Paper›PMID 41937685›Full record

ArticleIndian dermatology online journal2026

Cognitive Impairment among Patients with Chronic Skin Inflammatory Disorder: A Hidden Link.

Tarun Narang, Lalit K Singh, Muthu S Kumaran, Davinder Parsad, Aseem Mehra

Abstract read
In one paragraph

Article in Indian dermatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tarun NarangDepartment of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lalit K SinghDepartment of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Muthu S KumaranDepartment of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Davinder ParsadDepartment of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Aseem MehraDepartment of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.ORCID 0000-0002-5427-0247

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA limited number of studies have associated the prevalence of cognitive impairment among patients with chronic inflammatory skin disorders. AIM AND

objectiveThe objective of the study was to evaluate cognitive impairment among patients with chronic inflammatory skin disorders. PATIENTS AND

methodsThis was a cross-sectional study with a convenience sampling technique. A total of 200 patients with a diagnosis of psoriasis and vitiligo (100 each) were included. Participants were evaluated on the Hindi version of the Montreal cognitive assessment (MoCA) for cognitive impairment, patient health questionnaire-9 (PHQ-9) for depression, generalized anxiety disorder-7 (GAD-7) for anxiety disorder, and metabolic syndrome as per the consensus criteria given by the World Health Organization.

resultsA total of 200 patients were recruited. Those with psoriasis were significantly older ( P < 0.001), had notably fewer years of education ( P = 0.006), and were from rural areas ( P = 0.007).Those with psoriasis had a higher age at onset of illness ( P = 0.043), with a longer duration of illness ( P = 0.013), and reported significantly more presence of substance abuse ( P = 0.001). Overall, 68.5% had a presence of cognitive impairment. Those with psoriasis (75%) had a significantly higher frequency of cognitive impairment compared with those with vitiligo (62%). Those with psoriasis scored significantly low on the overall score of MoCA and all the domains of MoCA except orientation. These significant differences persisted even after controlling for factors such as the age of the patient, number of years of education, locality, age at onset of illness, duration of illness, substance use, alcohol use, tobacco use, hypertension, and central obesity. LIMITATIONS: It was a cross-sectional study; temporal association could not be elicited. Generalization of findings could not be done as only those who sought medical consultation from a tertiary care center were included. There was no age-gender matched control group.

conclusionThe prevalence of cognitive impairment was very high in patients with chronic inflammatory skin disorders. It is recommended to evaluate patients with psoriasis and vitiligo for cognitive impairment for early identification and treatment to prevent further deterioration of cognitive functions.

Indexed as

Identifiers

PMID41937685
PMCPMC13198812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.